Bottom line
Is LABX a good fund? The bottom line
LABX is a managed leveraged & inverse ETF from First Trust.
Its expense ratio is 1.3% — about $130 a year on every $10,000 invested, cheaper than 52% of leveraged & inverse funds we track.
With $136 million in net assets and 1 holdings, its largest position is Cfd Astera Labs Inc (118.7%) and the top 10 make up 118.7% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 118.7% of assets
Updated Nov 19, 2026
What LABX invests in
The Tradr 2X Long ALAB Daily ETF seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of ALAB. The Fund does not seek to achieve its stated investment objective for a period of time different than a single -trading day.
Under normal market circumstances, the Fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of ALAB. This may include ALAB stock in addition to financial instruments discussed below. The Fund is an actively -managed ETF that seeks to achieve on a daily basis, before fees and expenses, 200% performance of ALAB for a single -trading day, not for any other period, by entering into one or more swap agreements and/or purchasing listed options on ALAB and/or investing directly in the common stock of ALAB. A single -trading day is measured from the time the Fund calculates its net asset value (NAV) to the time of the Funds next NAV calculation. However, the use of option contracts or direct investments in common stock of ALAB is typically less efficient than swaps and may increase the likelihood that the Fund is…
From the fund's prospectus (filed Aug 4, 2026).
What LABX costs
On a $10,000 investment, LABX's 1.3% expense ratio costs about $130 a year. The prospectus estimates $1,568 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.
LABX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cfd Astera Labs Inc | 118.67% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 118.7% of the fund. See all top 25 holdings and asset mix →